home research news speak out calendar ideas guest book search
Go to UCP Homepage
 
Home News Research Congress Speak Out Calendar Feedback Search
Education Employment Health & Wellness
Housing Parenting & Families Products & Services
Sports & Leisure Transportation Travel
Your UCP: National October 13, 2003
Health & Wellness

Healthcare

CARF Approved to Accredit Opioid Treatment Programs

Tucson, AZ — November 26, 2001 — CARF… The Rehabilitation Accreditation Commission received approval by the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) to accredit opioid treatment programs in the United States.

More than 1,000 opioid treatment programs in the U.S. use methadone and similar pharmacotherapies for treatment and rehabilitation of people with dependence on narcotics. Under new SAMHSA guidelines, providers of opioid treatment programs must seek accreditation over the next two years. The approval of CARF as an accrediting body comes as the part of the federal government’s shift from regulatory oversight of opioid treatment programs by the FDA to a national accreditation model that is under SAMHSA oversight.

CARF establishes customer-focused standards to help providers measure and improve the quality of their programs. CARF first published a standards manual for opioid treatment programs in 1999, and will publish a revised standards manual in December 2001. A team of CARF surveyors observes a provider’s conformance and nonconformance to the standards during an on-site visit of an organization that is seeking accreditation. Based on the survey team’s findings, accreditation may be awarded to the organization for either a three- or one-year term or not at all.

CARF’s designation as one of four SAMHSA-approved accrediting bodies follows a 30-month contract with SAMHSA’s Center for Substance Abuse Treatment, in which CARF developed and implemented a national accreditation program for opioid treatment programs. CARF accredited 76 such programs across the country during the impact study of this project.

Opioid treatment providers interested in pursuing CARF accreditation may contact Bettye Harrison or Jennifer St. Clair to obtain survey application materials. Alternatively, organizations may call (520) 325-1044, ext. 128 or ext. 146.

Health & Wellness
General Information
CP Medical Research
Disability Research
Healthcare
Health Insurance Info
Sexuality
Therapy Options
Women with Disabilities
Advocacy
UCP Services
Resources
Discussion Group
LEARN ABOUT UCP:
About UCP
Research Foundation & Fact Sheets
Donate!
Corporate Sponsors
Public Policy
Media & Public Awareness
Grants & Contracts
Bellows Fund
Web Site Accessibility
En español
PRINTER-FRIENDLY VERSIONPrinter Friendly VersionSEND THIS ARTICLE TO A FRIENDSend This Article To A Friend
© 2003, UCP National (aka United Cerebral Palsy)
1660 L Street, NW, Suite 700, Washington, DC 20036
Phone: 800-872-5827/202-776-0406 TTY: 202-973-7197 Fax: 202-776-0414
E-Mail: webmaster@ucp.org
Affiliate Center Entrance
[password required]
Privacy Policy & Terms of Usage